Sudarshan Pharma Industries share news, announcements and annual reports
NSE: SUDARSHANBSE: 543828Chemicals & PetrochemicalsSmall Cap
Sudarshan Pharma Industries Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 2023 on BSE, Oct 2026 on NSE
Last close ₹35.16down ₹1.26 (3.46%)BSE ₹35.38
Share price at the NSE close on 2 Nov 2026. Previous close ₹36.42.
2 Nov: open ₹37.55, high ₹37.99, low ₹34.60
52-week range of BSE trades to 2 Nov 2026
₹18.50Low, 29 Jan 2026₹42.79High, 21 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹895 Cr1,697th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 30.82
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.58
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 1.99
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,14,083
Sudarshan Pharma Industries share news and announcements
248 announcements, routine notices left out, newest first. Page 2 of 5.
May 2026
12 May · Board meeting
Meeting on 15 May 2026
Apr 2026
27 Apr · Board meeting
Meeting on 30 Apr 2026: audited results
Feb 2026
18 Feb · Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
9 Feb · Legal
Exchange has sought clarification from Sudarshan Pharma Industries Ltd on February 09, 2026 with reference to significant movement in price, in order to ensure that investors have latest ....
Jan 2026
28 Jan · Results
22 Jan · Board meeting
Meeting on 28 Jan 2026: quarterly results14 Jan · Meeting
14 Jan · Meeting
Dec 2025
Oct 2025
18 Oct · Results
15 Oct · Board meeting
Meeting on 18 Oct 2025: half yearly results
Sep 2025
8 Sep · Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Aug 2025
11 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results
Jul 2025
25 Jul · Meeting
25 Jul · Meeting
Jun 2025
19 Jun · Announcement under Regulation 30 (LODR)-Issue of Securities
16 Jun · Board meeting
Meeting on 19 Jun 2025: annual general meeting